Cancer Archives · BioBuzz

Loading …

Gaithersburg’s VLP Therapeutics raises $16M Series A for cancer treatment vaccine R&D

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2021/03/VLP-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2021/03/VLP-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2021/03/VLP-75x75.jpg 75w" data-src="https://biobuzz.io/wp-content/uploads/2021/03/VLP-300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2021/03/VLP-300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2021/03/VLP-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2021/03/VLP-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2021/03/VLP-75x75.jpg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : March 15, 2021March 15, 2021 Published by : BioBuzz Media

VLP Therapeutics raises $16M Series A for cancer treatment vaccine R&D GAITHERSBURG, Md., March 15, 2021 /PRNewswire/ — US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on March 15 that it has raised US$16 million in a [….]

Baltimore’s Personal Genome Diagnostics and Fox Chase Cancer Center Announce Partnership to Broaden Liquid Biopsy Applications in Oncology Clinical Research

<img width="300" height="192" alt="" data-src="https://biobuzz.io/wp-content/uploads/2021/02/PGDx_PMS116_No_Full_name_TM_MED-300x192.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="192" src="https://biobuzz.io/wp-content/uploads/2021/02/PGDx_PMS116_No_Full_name_TM_MED-300x192.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" />

Published on : February 23, 2021February 23, 2021 Published by : Andy Eckert

Personal Genome Diagnostics and Fox Chase Cancer Center Announce Partnership to Broaden Liquid Biopsy Applications in Oncology Clinical Research BALTIMORE, Md.–(BUSINESS WIRE)–Personal Genome Diagnostics Inc. (PGDx), a leader in cancer [….]

Rockville’s Sensei Biotherapeutics Announces $30 Million Financing to Advance Clinical Pipeline of Oncology Therapeutics and Proprietary ImmunoPhage™ Platform

Published on : January 11, 2021January 21, 2021 Published by : BioBuzz Media

– Round co-led by Apeiron Investment Group and Catalio Capital Management – Proceeds support advancement of lead product candidate and next-generation platform for personalized yet off-the-shelf cancer immunotherapies BOSTON & [….]